{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:16:56Z","timestamp":1759483016170,"version":"3.30.2"},"reference-count":112,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,6,25]],"date-time":"2004-06-25T00:00:00Z","timestamp":1088121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Hepatitis C virus infection is often associated with extra\u2010hepatic manifestations, secondary to the elicitation of autoimmune reactions, generalized deposition of immune complexes and lymphoproliferative disorders. The most clearly established associations are those linking chronic hepatitis C with mixed cryoglobulinaemia (and the related glomerulonephritis and cutaneous vasculitis), as well as with the presence of autoantibodies. Less well\u2010documented disorders include non\u2010Hodgkin's lymphoma, thrombocytopenia, sialadenitis, thyroid disease, lichen planus, porphyria cutanea tarda, rheumatoid disorders and neurological disorders. Extra\u2010hepatic manifestations are most frequent in patients of female sex, advanced age, long\u2010lasting infection and cirrhosis. Optimal treatment strategies should be based on the predominant manifestation of the disease. In the case of autoimmune disorders not clearly attributable to the viral infection, corticosteroids may be the most effective option. Interferon\u2010\u03b1 alone or in combination with ribavirin may be indicated for those disorders related to immune complex deposition, such as mixed cryoglobulinaemia, although relapses of extra\u2010hepatic signs often occur on discontinuation of treatment. In some cases, interferon\u2010\u03b1 may induce or exacerbate some extra\u2010hepatic manifestations.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.01919.x","type":"journal-article","created":{"date-parts":[[2004,7,5]],"date-time":"2004-07-05T19:11:09Z","timestamp":1089054669000},"page":"129-141","source":"Crossref","is-referenced-by-count":25,"title":["Hepatitis C virus\u2010related extra\u2010hepatic disease \u2014 aetiopathogenesis and management"],"prefix":"10.1111","volume":"20","author":[{"given":"J.","family":"Medina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Garc\u00eda\u2010Buey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Moreno\u2010Otero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,6,25]]},"reference":[{"issue":"1","key":"e_1_2_26_2_2","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","article-title":"Course and outcome of hepatitis C","volume":"36","author":"Hoofnagle JH","year":"2002","journal-title":"Hepatology"},{"key":"e_1_2_26_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(99)80372-9"},{"key":"e_1_2_26_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200001000-00005"},{"key":"e_1_2_26_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.35620"},{"key":"e_1_2_26_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199211193272104"},{"issue":"9","key":"e_1_2_26_7_2","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1182\/blood.V84.9.3047.3047","article-title":"Low\u2010grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia","volume":"84","author":"Pozzato G","year":"1994","journal-title":"Blood"},{"key":"e_1_2_26_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-117-7-573"},{"key":"e_1_2_26_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840190407"},{"key":"e_1_2_26_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90022-1"},{"key":"e_1_2_26_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.1.4"},{"key":"e_1_2_26_12_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.6.3429"},{"issue":"4","key":"e_1_2_26_13_2","first-page":"1275","article-title":"Hepatitis C virus\u2010associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment","volume":"16","author":"Schott P","year":"2001","journal-title":"Histol Histopathol"},{"key":"e_1_2_26_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403173301104"},{"issue":"5","key":"e_1_2_26_15_2","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","article-title":"Interferon\u2010alpha in mixed cryoglobulinemia patients: a randomized, crossover\u2010controlled trial","volume":"81","author":"Ferri C","year":"1993","journal-title":"Blood"},{"issue":"1","key":"e_1_2_26_16_2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0168-8278(99)80404-8","article-title":"Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection","volume":"31","author":"Lunel F","year":"1999","journal-title":"J Hepatol"},{"key":"e_1_2_26_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1996.tb03273.x"},{"key":"e_1_2_26_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00581.x"},{"key":"e_1_2_26_19_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5390.938"},{"key":"e_1_2_26_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-7-200210010-00008"},{"key":"e_1_2_26_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.8.2910"},{"key":"e_1_2_26_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1537"},{"issue":"6","key":"e_1_2_26_23_2","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood.V91.6.2062","article-title":"Haplotype HLA\u2010B8\u2010DR3 confers susceptibility to hepatitis C virus\u2010related mixed cryoglobulinemia","volume":"91","author":"Lenzi M","year":"1998","journal-title":"Blood"},{"key":"e_1_2_26_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200109)44:9<2118::AID-ART364>3.0.CO;2-X"},{"issue":"298","key":"e_1_2_26_25_2","first-page":"101","article-title":"Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients","volume":"82","author":"Frankel AH","year":"1992","journal-title":"Q J Med"},{"issue":"10","key":"e_1_2_26_26_2","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V84.10.3336.3336","article-title":"Natural interferon\u2010alpha versus its combination with 6\u2010methyl\u2010prednisolone in the therapy of type II mixed cryoglobulinemia: a long\u2010term, randomized, controlled study","volume":"84","author":"Dammacco F","year":"1994","journal-title":"Blood"},{"key":"e_1_2_26_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240405"},{"issue":"10","key":"e_1_2_26_28_2","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V90.10.3865","article-title":"Predictors of long\u2010term response to high\u2010dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection","volume":"90","author":"Casato M","year":"1997","journal-title":"Blood"},{"issue":"9","key":"e_1_2_26_29_2","first-page":"2172","article-title":"Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon\u2010alpha","volume":"27","author":"Zuckerman E","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_26_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00067-3"},{"issue":"8","key":"e_1_2_26_31_2","first-page":"1775","article-title":"Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon","volume":"30","author":"Mazzaro C","year":"2003","journal-title":"J Rheumatol"},{"key":"e_1_2_26_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3162"},{"key":"e_1_2_26_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2856"},{"key":"e_1_2_26_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.1101"},{"key":"e_1_2_26_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4296.bloodjournal87104296"},{"key":"e_1_2_26_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3230"},{"key":"e_1_2_26_37_2","doi-asserted-by":"crossref","unstructured":"GisbertJ Garcia\u2010BueyL PajaresJ Moreno\u2010OteroR.Prevalence of hepatitis C virus infection in B\u2010cell non\u2010Hodgkin's lymphoma. Systematic review and meta\u2010analysis.Gastroenterology2003;125:1723\u201332.","DOI":"10.1053\/j.gastro.2003.09.025"},{"key":"e_1_2_26_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290224"},{"key":"e_1_2_26_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3745"},{"key":"e_1_2_26_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00069-8"},{"key":"e_1_2_26_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05848.x"},{"key":"e_1_2_26_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013376"},{"key":"e_1_2_26_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200243"},{"issue":"1","key":"e_1_2_26_44_2","first-page":"3","article-title":"Extrahepatic manifestations of chronic viral hepatitis","volume":"92","author":"Willson RA","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_26_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80021-3"},{"key":"e_1_2_26_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70116-B"},{"key":"e_1_2_26_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840170405"},{"key":"e_1_2_26_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90562-U"},{"key":"e_1_2_26_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840160603"},{"key":"e_1_2_26_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270627"},{"key":"e_1_2_26_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)90670-C"},{"key":"e_1_2_26_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210604"},{"key":"e_1_2_26_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(97)80011-4"},{"key":"e_1_2_26_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00346-5"},{"key":"e_1_2_26_55_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018854906444"},{"key":"e_1_2_26_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80438-2"},{"issue":"14","key":"e_1_2_26_57_2","first-page":"525","article-title":"Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C","volume":"44","author":"Okano J","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_26_58_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00009978"},{"key":"e_1_2_26_59_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310000672a"},{"key":"e_1_2_26_60_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.35072"},{"key":"e_1_2_26_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.1999.tb00089.x"},{"key":"e_1_2_26_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2003.10.009"},{"key":"e_1_2_26_63_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840360622"},{"key":"e_1_2_26_64_2","doi-asserted-by":"publisher","DOI":"10.1080\/000155598441990"},{"key":"e_1_2_26_65_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1995.tb03395.x"},{"key":"e_1_2_26_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)91029-H"},{"key":"e_1_2_26_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302183280703"},{"key":"e_1_2_26_68_2","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2003.02.1376"},{"key":"e_1_2_26_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)70152-X"},{"key":"e_1_2_26_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90628-2"},{"key":"e_1_2_26_71_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00022.x"},{"key":"e_1_2_26_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01257-3"},{"key":"e_1_2_26_73_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.6.1558"},{"key":"e_1_2_26_74_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2893.2001.00300.x"},{"key":"e_1_2_26_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg209"},{"issue":"2","key":"e_1_2_26_76_2","first-page":"842","article-title":"Pegylated (40 KDa) interferon alfa\u20102a (Pegasys TM) is unaffected by renal impairment [abstract]","volume":"32","author":"Martin P","year":"2000","journal-title":"Hepatology"},{"key":"e_1_2_26_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2003.08.009"},{"key":"e_1_2_26_78_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.34613"},{"issue":"12","key":"e_1_2_26_79_2","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1681\/ASN.V9122344","article-title":"Pharmacokinetics of alphaIFN\u20102b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications","volume":"9","author":"Rostaing L","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_26_80_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210302"},{"issue":"4","key":"e_1_2_26_81_2","first-page":"224","article-title":"Clinical manifestations and immunology associated with chronic infection with hepatitis C virus","volume":"202","author":"Garcia\u2010Carrasco M","year":"2002","journal-title":"Rev Clin Esp"},{"key":"e_1_2_26_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90020-9"},{"key":"e_1_2_26_83_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01389.x"},{"key":"e_1_2_26_84_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.3.406"},{"key":"e_1_2_26_85_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.04672.x"},{"key":"e_1_2_26_86_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-1-51"},{"key":"e_1_2_26_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90139-6"},{"key":"e_1_2_26_88_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.45"},{"key":"e_1_2_26_89_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-1-199507010-00004"},{"key":"e_1_2_26_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(05)80395-2"},{"key":"e_1_2_26_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840180205"},{"key":"e_1_2_26_92_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198911303212204"},{"key":"e_1_2_26_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90348-3"},{"key":"e_1_2_26_94_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.751768.x"},{"key":"e_1_2_26_95_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260127"},{"key":"e_1_2_26_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345087"},{"key":"e_1_2_26_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91645-O"},{"key":"e_1_2_26_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63964-8"},{"key":"e_1_2_26_99_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200203)32:3<903::AID-IMMU903>3.0.CO;2-D"},{"key":"e_1_2_26_100_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200101000-00001"},{"key":"e_1_2_26_101_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050388"},{"key":"e_1_2_26_102_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1526::AID-MUS23>3.0.CO;2-X"},{"key":"e_1_2_26_103_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg299"},{"key":"e_1_2_26_104_2","doi-asserted-by":"publisher","DOI":"10.1097\/00127893-200203000-00004"},{"key":"e_1_2_26_105_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199711000-00008"},{"key":"e_1_2_26_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80281-4"},{"key":"e_1_2_26_107_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199712000-00013"},{"key":"e_1_2_26_108_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V"},{"issue":"6","key":"e_1_2_26_109_2","first-page":"1115","article-title":"Ribavirin in hepatitis C related cryoglobulinemia","volume":"25","author":"Durand JM","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_26_110_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.500020403"},{"key":"e_1_2_26_111_2","doi-asserted-by":"publisher","DOI":"10.1080\/030097400750002139"},{"issue":"1","key":"e_1_2_26_112_2","first-page":"109","article-title":"Systemic vasculitis in patients with hepatitis C","volume":"28","author":"Cacoub P","year":"2001","journal-title":"J Rheumatol"},{"issue":"3","key":"e_1_2_26_113_2","first-page":"141","article-title":"Hepatitis C virus associated membranous glomerulonephritis","volume":"44","author":"Stehman\u2010Breen C","year":"1995","journal-title":"Clin Nephrol"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.01919.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.01919.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.01919.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T20:39:33Z","timestamp":1734467973000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.01919.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,25]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.1365-2036.2004.01919.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.01919.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"type":"print","value":"0269-2813"},{"type":"electronic","value":"1365-2036"}],"subject":[],"published":{"date-parts":[[2004,6,25]]}}}